DialysisEthics2_Forum
Other => Historical Posts => Topic started by: admin on September 24, 2009, 05:25:37 PM
-
Arlene
Site Admin
Joined: 02 Feb 2003
Posts: 52
PostPosted: Tue Mar 13, 2007 1:29 pm Post subject: NEED PATIENTS THAT HAVE BEEN INJURED BY EPO
I have reopened Dialysisethics.org....we are now in the process of starting a class action in the EPO!
What we said in 2000 about this industry is finally coming to fruition.
You can contact the lawyer through me or we will have a link direct to legal attorneys. It is strictly confidential.
I have stated before that this industry needed to be accountable. This is only the beginning.
WE will be going live with a new website that will handle HEALTHCARE issues. This will bring the dialysis issue to the forefront. We are
Healthcare Patient Rights LLC
We have a toll free phone number that is: 360-687-2298
email is :arlene@healthcarepatientrights.com
Feel free to contact me I will give you the numbers directly until the attorney link is up
*************************************************************************
leadsag
Joined: 31 Oct 2002
Posts: 263
PostPosted: Tue Mar 13, 2007 1:40 pm Post subject: EPO
Recently my Hemoglobin dropped into the 10's so I started getting EPO. My labs came up to 11.9......as we now know, the FDA has issued warning that it is dangerous to give dialysis patients EPO if the hemoglobin is above 12.0. THe unit claimed it was the company policy to give EPO if the hemoglobin is under 13.0. And then to keep giving it butg to reduce the dosage. I let them give me EPO for 2 treatments after the labs were 11.9 then started attempting to refuse it......
*************************************************************************
leadsag
Joined: 31 Oct 2002
Posts: 263
PostPosted: Tue Mar 13, 2007 1:46 pm Post subject: Payment System's Role in Overly Aggressive Use of Biologic
A recent article in the Biologic Drug Report ".......Epogen is used to treat anemia in some 1,300 DaVita centers that perform dialysis, a procedure to filter waste from the blood of patients with kidney-disease.
Gary Lieberman, an analyst at Stanford Group, said that for DaVita, buying Epogen from Amgen -- then obtaining reimbursement for each dose administered to dialysis patients -- makes up about [b:4667f37526]44 percent of the company's earnings [/b:4667f37526]before interest, taxes, depreciation and amortization......"
*************************************************************************
leadsag
Joined: 31 Oct 2002
Posts: 263
PostPosted: Tue Mar 13, 2007 1:49 pm Post subject: FDA Public Health Advisory
Patients with chronic kidney failure had an increased number of deaths and of non-fatal heart attacks, strokes, heart failure, and blood clots when ESAs were adjusted to maintain higher red blood cell levels (hemoglobin more than 12 g/dL). :!:
http://www.fda.gov/cder/drug/advisory/RHE2007.htm
*************************************************************************
Arlene
Site Admin
Joined: 02 Feb 2003
Posts: 52
PostPosted: Tue Mar 13, 2007 2:32 pm Post subject: Forgot to put on the email links
legal@healthcarepatientrights.com
legal@dialysisethiccs.org